Leukemia Research and Treatment / 2013 / Article / Tab 2

Clinical Study

Rapid Infusion Rituximab for Maintenance Therapy: Is It Feasible?

Table 2

Patient case.

Patient123
Age (years)465166
DiagnosisLow-grade follicular lymphomaCLL/SLLMarginal zone lymphoma
TreatmentCVP-R × 6 cyclesWeekly rituximab × 8 weeksR-CHOP × 1 cycle followed by 4 weeks of weekly rituximab
Maintenance scheduleQ 3 monthsWeekly × 4 weeks Q 6 monthsWeekly × 4 weeks Q 6 months
Dose no. with reaction5Course 2, week 1 (a) Course 3, week 1
(b) Course 3, week 2
Grade of reaction31(a) 3
(b) 3
Rapid rate rechallengeNoYesYes

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.